USP22 and cancer: Other studies suggest that USP22 overexpression induces enhanced resistance to apoptosis and treatment resistance in multiple cancer cell lines (Lin et al, 2012; Xu et al, 2012; Armour et al, 2013; Li et al, 2013; Li et al, 2014; Xiong et al, 2014).